{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:45:30Z","timestamp":1790808330488,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"China Human Proteome Project","award":["2014DFB30010,2014DFB30030"],"award-info":[{"award-number":["2014DFB30010,2014DFB30030"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31671377, 81472369"],"award-info":[{"award-number":["31671377, 81472369"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai 111 Project","award":["B14019"],"award-info":[{"award-number":["B14019"]}]},{"name":"Clinical Application Research Funds of Capital Beijing","award":["Z171100001017051"],"award-info":[{"award-number":["Z171100001017051"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Berardinelli-Seip congenital lipodystrophy (BSCL) is a heterogeneous autosomal recessive disorder characterized by an almost total lack of adipose tissue in the body. Mutations in the <jats:italic>AGPAT2<\/jats:italic>, <jats:italic>BSCL2<\/jats:italic>, <jats:italic>CAV1<\/jats:italic> and <jats:italic>PTRF<\/jats:italic> genes define I-IV subtype of BSLC respectively and clinical data indicate that new causative genes remain to be discovered. Here, we retrieved 341 cases from 60 BSCL-related studies worldwide and aimed to explore genotype-phenotype correlations based on mutations of AGPAT2 and BSCL2 genes from 251 cases. We also inferred new candidate genes for BSCL through protein-protein interaction and phenotype-similarity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Analysis results show that BSCL type II with earlier age of onset of diabetes mellitus, higher risk to suffer from premature death and mental retardation, is a more severe disorder than BSCL type I, but BSCL type I patients are more likely to have bone cysts. In BSCL type I, females are at higher risk of developing diabetes mellitus and acanthosis nigricans than males, while in BSCL type II, males suffer from diabetes mellitus earlier than females. In addition, some significant correlations among BSCL-related phenotypes were identified. New candidate genes prediction through protein-protein interaction and phenotype-similarity was conducted and we found that CAV3, EBP, SNAP29, HK1, CHRM3, OBSL1 and DNAJC13 genes could be the pathogenic factors for BSCL. Particularly, CAV3 and EBP could be high-priority candidate genes contributing to pathogenesis of BSCL.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study largely enhances the current knowledge of phenotypic and genotypic heterogeneity of BSCL and promotes the more comprehensive understanding of pathogenic mechanisms for BSCL.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-020-01383-y","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T21:16:19Z","timestamp":1588194979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Genotype-phenotype correlations of Berardinelli-Seip congenital lipodystrophy and novel candidate genes prediction"],"prefix":"10.1186","volume":"15","author":[{"given":"Meng","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmeng","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongli","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tieliu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,29]]},"reference":[{"key":"1383_CR1","first-page":"555","volume":"48","author":"M Seip","year":"1959","unstructured":"Seip M. Lipodystrophy and gigantism with associated endocrine manifestations. A new diencephalic syndrome? Acta Paediatr. 1959;48:555\u201374.","journal-title":"Acta Paediatr"},{"key":"1383_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1651-2227.1996.tb14262.x","volume":"413","author":"M Seip","year":"1996","unstructured":"Seip M, Trygstad O. Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr Suppl. 1996;413:2\u201328.","journal-title":"Acta Paediatr Suppl"},{"issue":"10","key":"1383_CR3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1136\/jmg.39.10.722","volume":"39","author":"L Van Maldergem","year":"2002","unstructured":"Van Maldergem L, Magre J, Khallouf TE, Gedde-Dahl T Jr, Delepine M, Trygstad O, et al. Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy. J Med Genet. 2002;39(10):722\u201333.","journal-title":"J Med Genet"},{"issue":"10","key":"1383_CR4","first-page":"3077","volume":"80","author":"M Chandalia","year":"1995","unstructured":"Chandalia M, Garg A, Vuitch F, Nizzi F. Postmortem findings in congenital generalized lipodystrophy. J Clin Endocrinol Metab. 1995;80(10):3077\u201381.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1383_CR5","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrendo.2015.123","volume":"11","author":"N Patni","year":"2015","unstructured":"Patni N, Garg A. Congenital generalized lipodystrophies--new insights into metabolic dysfunction. Nat Rev Endocrinol. 2015;11(9):522\u201334.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1383_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.metabol.2004.08.021","volume":"54","author":"C Musso","year":"2005","unstructured":"Musso C, Cochran E, Javor E, Young J, Depaoli AM, Gorden P. The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients. Metabolism. 2005;54(2):255\u201363.","journal-title":"Metabolism."},{"issue":"2 Pt 2","key":"1383_CR7","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/AOG.0b013e31822cecf7","volume":"119","author":"M Maguire","year":"2012","unstructured":"Maguire M, Lungu A, Gorden P, Cochran E, Stratton P. Pregnancy in a woman with congenital generalized lipodystrophy: leptin's vital role in reproduction. Obstet Gynecol. 2012;119(2 Pt 2):452\u20135.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"1383_CR8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1365-2265.2009.03532.x","volume":"71","author":"DM Miranda","year":"2009","unstructured":"Miranda DM, Wajchenberg BL, Calsolari MR, Aguiar MJ, Silva JM, Ribeiro MG, et al. Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berardinelli-Seip congenital generalized lipodystrophy syndrome. Clin Endocrinol (Oxf). 2009;71(4):512\u20137.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"1383_CR9","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1210\/jc.2003-030415","volume":"89","author":"KB Gomes","year":"2004","unstructured":"Gomes KB, Fernandes AP, Ferreira AC, Pardini H, Garg A, Magre J, et al. Mutations in the seipin and AGPAT2 genes clustering in consanguineous families with Berardinelli-Seip congenital lipodystrophy from two separate geographical regions of Brazil. J Clin Endocrinol Metab. 2004;89(1):357\u201361.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1383_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/ng585","volume":"28","author":"J Magre","year":"2001","unstructured":"Magre J, Delepine M, Khallouf E, Gedde-Dahl T Jr, Van Maldergem L, Sobel E, et al. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet. 2001;28(4):365\u201370.","journal-title":"Nat Genet"},{"issue":"6","key":"1383_CR11","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.celrep.2016.10.037","volume":"17","author":"M Pagac","year":"2016","unstructured":"Pagac M, Cooper DE, Qi Y, Lukmantara IE, Mak HY, Wu Z, et al. SEIPIN regulates lipid droplet expansion and adipocyte development by modulating the activity of Glycerol-3-phosphate Acyltransferase. Cell Rep. 2016;17(6):1546\u201359.","journal-title":"Cell Rep"},{"issue":"1","key":"1383_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/ng880","volume":"31","author":"AK Agarwal","year":"2002","unstructured":"Agarwal AK, Arioglu E, De Almeida S, Akkoc N, Taylor SI, Bowcock AM, et al. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet. 2002;31(1):21\u20133.","journal-title":"Nat Genet"},{"key":"1383_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.genom.7.080505.115715","volume":"7","author":"AK Agarwal","year":"2006","unstructured":"Agarwal AK, Garg A. Genetic disorders of adipose tissue development, differentiation, and death. Annu Rev Genomics Hum Genet. 2006;7:175\u201399.","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"4","key":"1383_CR14","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1210\/jc.2007-1328","volume":"93","author":"CA Kim","year":"2008","unstructured":"Kim CA, Delepine M, Boutet E, El Mourabit H, Le Lay S, Meier M, et al. Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J Clin Endocrinol Metab. 2008;93(4):1129\u201334.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1383_CR15","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1172\/JCI200114611","volume":"108","author":"B Razani","year":"2001","unstructured":"Razani B, Lisanti MP. Caveolin-deficient mice: insights into caveolar function human disease. J Clin Invest. 2001;108(11):1553\u201361.","journal-title":"J Clin Invest"},{"issue":"9","key":"1383_CR16","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1172\/JCI38660","volume":"119","author":"YK Hayashi","year":"2009","unstructured":"Hayashi YK, Matsuda C, Ogawa M, Goto K, Tominaga K, Mitsuhashi S, et al. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. J Clin Invest. 2009;119(9):2623\u201333.","journal-title":"J Clin Invest"},{"issue":"3","key":"1383_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000874","volume":"6","author":"A Rajab","year":"2010","unstructured":"Rajab A, Straub V, McCann LJ, Seelow D, Varon R, Barresi R, et al. Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations. PLoS Genet. 2010;6(3):e1000874.","journal-title":"PLoS Genet"},{"issue":"7","key":"1383_CR18","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1074\/jbc.M707890200","volume":"283","author":"L Liu","year":"2008","unstructured":"Liu L, Pilch PF. A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization. J Biol Chem. 2008;283(7):4314\u201322.","journal-title":"J Biol Chem"},{"key":"1383_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1750-1172-8-119","volume":"8","author":"B Knebel","year":"2013","unstructured":"Knebel B, Kotzka J, Lehr S, Hartwig S, Avci H, Jacob S, et al. A mutation in the c-fos gene associated with congenital generalized lipodystrophy. Orphanet J Rare Dis. 2013;8:119.","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"1383_CR20","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1210\/jc.2003-030855","volume":"88","author":"AK Agarwal","year":"2003","unstructured":"Agarwal AK, Simha V, Oral EA, Moran SA, Gorden P, O'Rahilly S, et al. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J Clin Endocrinol Metab. 2003;88(10):4840\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1383_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/jhg.2013.107","volume":"59","author":"T Nolis","year":"2014","unstructured":"Nolis T. Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies. J Hum Genet. 2014;59(1):16\u201323.","journal-title":"J Hum Genet"},{"key":"1383_CR22","volume-title":"Berardinelli-Seip Congenital Lipodystrophy","author":"L Van Maldergem","year":"1993","unstructured":"Van Maldergem L. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, LJH B, Stephens K, et al., editors. Berardinelli-Seip Congenital Lipodystrophy. Seattle: GeneReviews((R)); 1993."},{"key":"1383_CR23","doi-asserted-by":"crossref","unstructured":"Ferraria N, Pedrosa C, Amaral D, Lopes L. Berardinelli-Seip syndrome: highlight of treatment challenge. BMJ Case Rep. 2013;2013.","DOI":"10.1136\/bcr-2012-007734"},{"key":"1383_CR24","doi-asserted-by":"crossref","unstructured":"Lima JG, Nobrega LHC, Lima NN, Dos Santos MCF, Silva PHD, Baracho MFP, et al. Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy. PLoS One. 2018;13(6):e0199052.","DOI":"10.1371\/journal.pone.0199052"},{"key":"1383_CR25","doi-asserted-by":"crossref","unstructured":"Haghighi A, Kavehmanesh Z, Haghighi A, Salehzadeh F, Santos-Simarro F, Van Maldergem L, et al. Congenital generalized lipodystrophy: identification of novel variants and expansion of clinical spectrum. Clin Genet. 2016;89(4):434\u201341.","DOI":"10.1111\/cge.12623"},{"key":"1383_CR26","doi-asserted-by":"crossref","unstructured":"Akinci G, Topaloglu H, Akinci B, Onay H, Karadeniz C, Ergul Y, et al. Spectrum of clinical manifestations in two young Turkish patients with congenital generalized lipodystrophy type 4. Eur J Med Genet. 2016;59(6-7):320\u20134.","DOI":"10.1016\/j.ejmg.2016.05.001"},{"key":"1383_CR27","doi-asserted-by":"crossref","unstructured":"Araujo-Vilar D, Sanchez-Iglesias S, Guillin-Amarelle C, Castro A, Lage M, Pazos M, et al. Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience. Endocrine. 2015;49(1):139\u201347.","DOI":"10.1007\/s12020-014-0450-4"},{"key":"1383_CR28","doi-asserted-by":"crossref","unstructured":"Fu M, Kazlauskaite R, Baracho Mde F, Santos MG, Brandao-Neto J, Villares S, et al. Mutations in Gng3lg and AGPAT2 in Berardinelli-Seip congenital lipodystrophy and Brunzell syndrome: phenotype variability suggests important modifier effects. J Clin Endocrinol Metab. 2004;89(6):2916\u201322.","DOI":"10.1210\/jc.2003-030485"},{"key":"1383_CR29","doi-asserted-by":"crossref","unstructured":"Opri R, Fabrizi GM, Cantalupo G, Ferrarini M, Simonati A, Dalla Bernardina B, et al. Progressive Myoclonus Epilepsy in Congenital Generalized Lipodystrophy type 2: Report of 3 cases and literature review. Seizure. 2016;42:1\u20136.","DOI":"10.1016\/j.seizure.2016.08.008"},{"key":"1383_CR30","doi-asserted-by":"crossref","unstructured":"Ben Turkia H, Tebib N, Azzouz H, Abdelmoula MS, Ben Chehida A, Hubert P, et al. [Congenital generalized lipodystrophy: a case report with neurological involvement]. Arch Pediatr. 2009;16(1):27\u201331.","DOI":"10.1016\/j.arcped.2008.10.005"},{"key":"1383_CR31","doi-asserted-by":"crossref","unstructured":"Bhayana S, Siu VM, Joubert GI, Clarson CL, Cao H, Hegele RA. Cardiomyopathy in congenital complete lipodystrophy. Clin Genet. 2002;61(4):283\u20137.","DOI":"10.1034\/j.1399-0004.2002.610407.x"},{"key":"1383_CR32","doi-asserted-by":"crossref","unstructured":"Debray FG, Baguette C, Colinet S, Van Maldergem L, Verellen-Dumouin C. Early infantile cardiomyopathy and liver disease: a multisystemic disorder caused by congenital lipodystrophy. Mol Genet Metab. 2013;109(2):227\u20139.","DOI":"10.1016\/j.ymgme.2013.04.011"},{"key":"1383_CR33","doi-asserted-by":"crossref","unstructured":"Huang HH, Chen TH, Hsiao HP, Huang CT, Wang CC, Shiau YH, et al. A Taiwanese boy with congenital generalized lipodystrophy caused by homozygous Ile262fs mutation in the BSCL2 gene. Kaohsiung J Med Sci. 2010;26(11):615\u201320.","DOI":"10.1016\/S1607-551X(10)70094-2"},{"key":"1383_CR34","doi-asserted-by":"crossref","unstructured":"Shirwalkar HU, Patel ZM, Magre J, Hilbert P, Van Maldergem L, Mukhopadhyay RR, et al. Congenital generalized lipodystrophy in an Indian patient with a novel mutation in BSCL2 gene. J Inherit Metab Dis. 2008;31 Suppl 2:S317\u201322.","DOI":"10.1007\/s10545-008-0899-5"},{"key":"1383_CR35","doi-asserted-by":"crossref","unstructured":"Ebihara K, Kusakabe T, Masuzaki H, Kobayashi N, Tanaka T, Chusho H, et al. Gene and phenotype analysis of congenital generalized lipodystrophy in Japanese: a novel homozygous nonsense mutation in seipin gene. J Clin Endocrinol Metab. 2004;89(5):2360\u20134.","DOI":"10.1210\/jc.2003-031211"},{"key":"1383_CR36","doi-asserted-by":"crossref","unstructured":"Nishiyama A, Yagi M, Awano H, Okizuka Y, Maeda T, Yoshida S, et al. Two Japanese infants with congenital generalized lipodystrophy due to BSCL2 mutations. Pediatr Int. 2009;51(6):775\u20139.","DOI":"10.1111\/j.1442-200X.2009.02863.x"},{"key":"1383_CR37","doi-asserted-by":"crossref","unstructured":"Jin J, Cao L, Zhao Z, Shen S, Kiess W, Zhi D, et al. Novel BSCL2 gene mutation E189X in Chinese congenital generalized lipodystrophy child with early onset diabetes mellitus. Eur J Endocrinol. 2007;157(6):783\u20137.","DOI":"10.1530\/EJE-07-0393"},{"key":"1383_CR38","doi-asserted-by":"crossref","unstructured":"Friguls B, Coroleu W, del Alcazar R, Hilbert P, Van Maldergem L, Pintos-Morell G. Severe cardiac phenotype of Berardinelli-Seip congenital lipodystrophy in an infant with homozygous E189X BSCL2 mutation. Eur J Med Genet. 2009;52(1):14\u20136.","DOI":"10.1016\/j.ejmg.2008.10.006"},{"key":"1383_CR39","doi-asserted-by":"crossref","unstructured":"Haghighi A, Razzaghy-Azar M, Talea A, Sadeghian M, Ellard S, Haghighi A. Identification of a novel nonsense mutation and a missense substitution in the AGPAT2 gene causing congenital generalized lipodystrophy type 1. Eur J Med Genet. 2012;55(11):620\u20134.","DOI":"10.1016\/j.ejmg.2012.07.011"},{"key":"1383_CR40","doi-asserted-by":"crossref","unstructured":"Hann G, Salam A, Kapila P. An incidental finding of striking muscular hypertrophy leading to a diagnosis of Berardinelli Seip Congenital Lipodystrophy. Arch Dis Child. 2013;98(12):933.","DOI":"10.1136\/archdischild-2013-303691"},{"key":"1383_CR41","doi-asserted-by":"crossref","unstructured":"Jeninga EH, de Vroede M, Hamers N, Breur JM, Verhoeven-Duif NM, Berger R, et al. A Patient with Congenital Generalized Lipodystrophy Due To a Novel Mutation in BSCL2: Indications for Secondary Mitochondrial Dysfunction. JIMD Rep. 2012;4:47\u201354.","DOI":"10.1007\/8904_2011_86"},{"key":"1383_CR42","doi-asserted-by":"crossref","unstructured":"Metwalley KA, Farghaly HS. Berardinelli-Seip syndrome type 1 in an Egyptian child. Indian J Hum Genet. 2014;20(1):75\u20138.","DOI":"10.4103\/0971-6866.132762"},{"key":"1383_CR43","doi-asserted-by":"crossref","unstructured":"Solanki M, Patil SS, Baweja DK, Noorani H, Pk S. Talon cusps, macrodontia, and aberrant tooth morphology in Berardinelli-Seip syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105(1):e41\u20137.","DOI":"10.1016\/j.tripleo.2007.07.022"},{"key":"1383_CR44","doi-asserted-by":"crossref","unstructured":"Victoria B, Cabezas-Agricola JM, Gonzalez-Mendez B, Lattanzi G, Del Coco R, Loidi L, et al. Reduced adipogenic gene expression in fibroblasts from a patient with type 2 congenital generalized lipodystrophy. Diabet Med. 2010;27(10):1178\u201387.","DOI":"10.1111\/j.1464-5491.2010.03052.x"},{"key":"1383_CR45","doi-asserted-by":"crossref","unstructured":"Simsir IY, Yurekli BS, Saygili F, Altay C, Akinci B. First metreleptin treatment for generalized lipodystrophy in Turkey. Diabetes Obes Metab. 2017;19(2):299\u2013301.","DOI":"10.1111\/dom.12796"},{"key":"1383_CR46","doi-asserted-by":"crossref","unstructured":"Purizaca-Rosillo N, Mori T, Benites-Condor Y, Hisama FM, Martin GM, Oshima J. High incidence of BSCL2 intragenic recombinational mutation in Peruvian type 2 Berardinelli-Seip syndrome. Am J Med Genet A. 2017;173(2):471\u20138.","DOI":"10.1002\/ajmg.a.38053"},{"key":"1383_CR47","doi-asserted-by":"crossref","unstructured":"Su X, Lin R, Huang Y, Sheng H, Li X, Ting TH, et al. Clinical and Mutational Features of Three Chinese Children with Congenital Generalized Lipodystrophy. J Clin Res Pediatr Endocrinol. 2017;9(1):52\u20137.","DOI":"10.4274\/jcrpe.3556"},{"key":"1383_CR48","doi-asserted-by":"crossref","unstructured":"Chen R, Yuan X, Wang J, Zhang Y. Clinical and molecular characterization of two Chinese patients with Type 2 congenital generalized lipodystrophy. Gene. 2017;637:57\u201362.","DOI":"10.1016\/j.gene.2017.09.023"},{"key":"1383_CR49","doi-asserted-by":"crossref","unstructured":"Ponte CMM, Fernandes VO, Gurgel MHC, Vasconcelos I, Karbage L, Liberato CBR, et al. Early commitment of cardiovascular autonomic modulation in Brazilian patients with congenital generalized lipodystrophy. BMC Cardiovasc Disord. 2018;18(1):6.","DOI":"10.1186\/s12872-017-0738-4"},{"key":"1383_CR50","doi-asserted-by":"crossref","unstructured":"Lima JG, Nobrega LHC, Lima NN, Dos Santos MCF, Baracho MFP, Winzenrieth R, et al. Normal bone density and trabecular bone score, but high serum sclerostin in congenital generalized lipodystrophy. Bone. 2017;101:21\u20135.","DOI":"10.1016\/j.bone.2017.03.053"},{"key":"1383_CR51","doi-asserted-by":"crossref","unstructured":"Dantas de Medeiros JL, Carneiro Bezerra B, Brito de Araujo TA, Craveiro Sarmento AS, de Azevedo Medeiros LB, Peroni Gualdi L, et al. Impairment of respiratory muscle strength in Berardinelli-Seip congenital lipodystrophy subjects. Respir Res. 2018;19(1):173.","DOI":"10.1186\/s12931-018-0879-8"},{"key":"1383_CR52","doi-asserted-by":"crossref","unstructured":"Gonzalo MM, Estefania CV. Congenital Generalized Lipodystrophy Type 2 in a Patient From a High-Prevalence Area. J Endocr Soc. 2017;1(8):1012\u20134.","DOI":"10.1210\/js.2017-00141"},{"key":"1383_CR53","doi-asserted-by":"crossref","unstructured":"Lindahl K, Astrom E, Rubin CJ, Grigelioniene G, Malmgren B, Ljunggren O, et al. Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta. Eur J Hum Genet. 2015;23(8):1112.","DOI":"10.1038\/ejhg.2015.129"},{"key":"1383_CR54","doi-asserted-by":"crossref","unstructured":"Huttlin EL, Bruckner RJ, Paulo JA, Cannon JR, Ting L, Baltier K, et al. Architecture of the human interactome defines protein communities and disease networks. Nature. 2017;545(7655):505\u20139.","DOI":"10.1038\/nature22366"},{"key":"1383_CR55","doi-asserted-by":"crossref","unstructured":"Chatr-Aryamontri A, Oughtred R, Boucher L, Rust J, Chang C, Kolas NK, et al. The BioGRID interaction database: 2017 update. Nucleic Acids Res. 2017;45(D1):D369\u2013D79.","DOI":"10.1093\/nar\/gkw1102"},{"key":"1383_CR56","unstructured":"Kohler S, Vasilevsky NA, Engelstad M, Foster E, McMurry J, Ayme S, et al. The Human Phenotype Ontology in 2017. Nucleic Acids Res. 2017;45(D1):D865\u2013D76."},{"key":"1383_CR57","doi-asserted-by":"crossref","unstructured":"McMahon KA, Zajicek H, Li WP, Peyton MJ, Minna JD, Hernandez VJ, et al. SRBC\/cavin-3 is a caveolin adapter protein that regulates caveolae function. EMBO J. 2009;28(8):1001\u201315.","DOI":"10.1038\/emboj.2009.46"},{"key":"1383_CR58","doi-asserted-by":"crossref","unstructured":"Consortium GT. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013;45(6):580\u20135.","DOI":"10.1038\/ng.2653"},{"key":"1383_CR59","doi-asserted-by":"crossref","unstructured":"Bai D, Zhao J, Li L, Gao J, Wang X. Analysis of genotypes and phenotypes in Chinese children with tuberous sclerosis complex. Sci China Life Sci. 2017;60(7):763\u201371.","DOI":"10.1007\/s11427-017-9091-x"},{"key":"1383_CR60","doi-asserted-by":"crossref","unstructured":"Shen Y, Qiu X, Gui B, He S, Huang H, Xue J, et al. Implementing comprehensive genetic carrier screening in China\u2015Harnessing the power of genomic medicine for the effective prevention\/management of birth defects and rare genetic diseases in China. Pediatr Investig. 2018;2(1):30\u20136.","DOI":"10.1002\/ped4.12021"},{"key":"1383_CR61","doi-asserted-by":"crossref","unstructured":"Shen Y. Next-generation sequencing based molecular testing is an equalizer for diagnostic service of rare genetic disorders in China. Pediatr Investig. 2018;2(2):96\u20137.","DOI":"10.1002\/ped4.12036"},{"key":"1383_CR62","doi-asserted-by":"crossref","unstructured":"Bao Y, Suo L, Qian P, Huang H, Yang Y, Tang J, et al. Clinical and genetic analysis of Dent disease with nephrotic range albuminuria in Shaanxi, China. Sci China Life Sci. 2019;62(12):1590\u20133.","DOI":"10.1007\/s11427-018-9829-0"},{"key":"1383_CR63","doi-asserted-by":"crossref","unstructured":"Li Z, Zhu P, Huang H, Pan Y, Han P, Cui H, et al. Identification of a novel COL4A5 mutation in the proband initially diagnosed as IgAN from a Chinese family with X-linked Alport syndrome. Sci China Life Sci. 2019;62(12):1572\u20139.","DOI":"10.1007\/s11427-018-9545-3"},{"key":"1383_CR64","doi-asserted-by":"crossref","unstructured":"Mercier I, Jasmin JF, Pavlides S, Minetti C, Flomenberg N, Pestell RG, et al. Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders. Lab Invest. 2009;89(6):614\u201323.","DOI":"10.1038\/labinvest.2009.23"},{"key":"1383_CR65","doi-asserted-by":"crossref","unstructured":"Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, et al. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem. 1996;271(25):15160\u20135.","DOI":"10.1074\/jbc.271.25.15160"},{"key":"1383_CR66","doi-asserted-by":"crossref","unstructured":"Capozza F, Combs TP, Cohen AW, Cho YR, Park SY, Schubert W, et al. Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. Am J Physiol Cell Physiol. 2005;288(6):C1317\u201331.","DOI":"10.1152\/ajpcell.00489.2004"},{"key":"1383_CR67","doi-asserted-by":"crossref","unstructured":"Talukder MA, Preda M, Ryzhova L, Prudovsky I, Pinz IM. Heterozygous caveolin-3 mice show increased susceptibility to palmitate-induced insulin resistance. Physiol Rep. 2016;4(6).","DOI":"10.14814\/phy2.12736"},{"key":"1383_CR68","doi-asserted-by":"crossref","unstructured":"Graul-Neumann LM, Kienitz T, Robinson PN, Baasanjav S, Karow B, Gillessen-Kaesbach G, et al. Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3' terminus of the FBN1-gene. Am J Med Genet A. 2010;152A(11):2749\u201355.","DOI":"10.1002\/ajmg.a.33690"},{"key":"1383_CR69","doi-asserted-by":"crossref","unstructured":"Silve S, Dupuy PH, Labit-Lebouteiller C, Kaghad M, Chalon P, Rahier A, et al. Emopamil-binding protein, a mammalian protein that binds a series of structurally diverse neuroprotective agents, exhibits delta8-delta7 sterol isomerase activity in yeast. J Biol Chem. 1996;271(37):22434\u201340.","DOI":"10.1074\/jbc.271.37.22434"},{"key":"1383_CR70","doi-asserted-by":"crossref","unstructured":"Moebius FF, Fitzky BU, Wietzorrek G, Haidekker A, Eder A, Glossmann H. Cloning of an emopamil-binding protein (EBP)-like protein that lacks sterol delta8-delta7 isomerase activity. Biochem J. 2003;374(Pt 1):229\u201337.","DOI":"10.1042\/bj20030465"},{"key":"1383_CR71","doi-asserted-by":"crossref","unstructured":"Anderson RG. The caveolae membrane system. Annu Rev Biochem. 1998;67:199\u2013225.","DOI":"10.1146\/annurev.biochem.67.1.199"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01383-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-020-01383-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01383-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:03:46Z","timestamp":1619654626000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01383-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,29]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1383"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01383-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,29]]},"assertion":[{"value":"24 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study did not involve any primary data collection.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}